Biotech Values

[tony111]

They have 1Q of cash left to burn. How can they advance the trial without raising cash. Its a pure fantasy to get partner this early. Look at ANDS when they announced their interim phase 1 data. Having higher share price as leverage is just bullcrap especially when the HCV arena is extremely crowded and all the companies will be testing combos not single agents.